These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The change of platelet derived growth factor in patients with obstructive sleep apnea-hypopnea syndrome].
    Author: Liu HG, Lin M, Guan P, Xu YJ.
    Journal: Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):536-40. PubMed ID: 17074267.
    Abstract:
    OBJECTIVE: To observe the change of platelet derived growth factor-B (PDGF-B) in obstructive sleep apnea-hypopnea syndrome (OSAHS) patients, and to explore the relationship of PDGF-BB, OSAHS and complicated cardiovascular diseases. METHODS: The levels of serum PDGF-BB in 40 OSAHS patients and 20 healthy controls were measured by enzyme-linked immunosorbent assay (ELISA) method. The levels of PDGF-B mRNA in peripheral blood mononuclear cells were measured by reverse transcription polymerase chain reaction (RT-PCR). RESULTS: The serum levels of PDGF-BB and the levels of PDGF-B mRNA in peripheral blood mononuclear cells were significantly higher in OSAHS group [mild, moderate, severe level was (477 +/- 115), (736 +/- 126), (1,046 +/- 137) ng/L, and (0.7 +/- 0.1), (1.0 +/- 0.2), (1.3 +/- 0.2) respectively] than those in control group [(151 +/- 19) ng/L, 0.4 +/- 0.1, F = 102.59, 58.75, P < 0.01] and PDGF-BB related with severity of OSAHS. There was a positive correlation between PDGF-BB level and AHI as well as average angiosthenia (P < 0.05). Also, there was a positive correlation between PDGF-BB level and percentage of time spent when oxygen saturation lower than 90% (SLT90%) (P < 0.05). There was a negative correlation between PDGF-BB and average saturation of blood oxygen as well as lowest saturation of blood oxygen (P < 0.05). After nCPAP, the levels of PDGF and PDGF-B mRNA in OSAHS patients [before treatment: (1,046 +/- 137) ng/L, (1.3 +/- 0.2), after treatment: (699 +/- 130) ng/L, (0.7 +/- 0.2)] reduced significantly, but still higher then those of control group [(151 +/- 19) ng/L, 0.4 +/- 0.1, F = 82.21, 154.24, P < 0.01]. CONCLUSION: The level of PDGF-BB in OSAHS is increased increases, which may play a role in the pathophysiology of OSAHS and complicated cardiovascular diseases.
    [Abstract] [Full Text] [Related] [New Search]